Luther King Capital Management (LKCM)
AMED

Luther King Capital Management (LKCM)’s Amedisys AMED Stock Holding History

Luther King Capital Management (LKCM)’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-775
Closed -$227K – 552
2020
Q4 		$227K Buy
+775
New +$199K ﹤0.01% 524

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Luther King Capital Management (LKCM)'s AMED Position: Q1 2021 in Review

Luther King Capital Management (LKCM) sold out of Amedisys (AMED) in Q1 2021, closing a stake of 775 shares — an estimated $227K sold.

Luther King Capital Management (LKCM) first reported a position in AMED in Q4 2020 and held it in 1 quarter. The position peaked at $227K in Q4 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • Luther King Capital Management (LKCM) reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • Luther King Capital Management (LKCM) sold 775 Amedisys shares in Q1 2021, an estimated $227K.
  • Luther King Capital Management (LKCM) first reported a position in Amedisys in Q4 2020 and held it in 1 quarter.
  • Luther King Capital Management (LKCM)'s Amedisys position peaked at $227K in Q4 2020.
  • 388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q1 2021, filed 12 May 2021.